Skip to main content
Delayed Sleep-Wake Phase DisorderSleepDiagnostics and screeningCombination product

What this study is

The goal of this observational study is to characterize the pupil light response in patients with delayed sleep-wake phase disorder. A subset of participants will take part in a clinical trial to determine if increasing serotonin can alter the circadian response to light. The main questions it aims to answer is:

Are there differences in the light response in patients with delayed sleep-wake phase disorder? Does citalopram increase melatonin suppression in patients with delayed sleep-wake phase disorder?

Participants will complete activity and melatonin testing at home to determine their circadian timing. This will be followed by an eye test looking at the pupil response to different light stimuli. A subset of participants will complete two inpatient admissions where melatonin levels will be sampled and they will be exposed to a bright light. During one round of testing they will receive a placebo and in the other round of testing they will take a single dose of citalopram, a selective serotonin reuptake inhibitor.

What's being tested

  • Light and Citalopram

    Intervention · COMBINATION PRODUCT

    Participants will receive placebo or citalopram, followed by bright light exposure

Study details

Official title
Pupillometry in DSWPD Type 1 and Type 2
Sponsor
Northwestern University
Conditions
Delayed Sleep-Wake Phase Disorder
Enrolling
220 people
Starts
2025-09-01
Est. completion
2029-08-31
Design
Open-label, single group
Record
View on ClinicalTrials.gov ↗